Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORS vs IV Saline for Orthostatic Intolerance in ME/CFS
NCT02854683Phase 1Unknown
- Sponsor
- New York Medical College
- Start
- Feb 2016
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of low osmolar oral rehydration salts in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS) and Neurally mediated syncope (NMS), sponsored by New York Medical College. Primary endpoints: Total Blood Volume at 1 week and Cardiac Output at 1 week. Status: unknown.
02
Drugs
low osmolar oral rehydration salts
03
Conditions
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)postural orthostatic tachycardia syndrome (POTS)Neurally mediated syncope (NMS)
Beyond the preview
Go deeper on NCT02854683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854683.